Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

20.36 +1.53 (+8.13%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health Inc

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
SVB Securities Sees 26% Downside In This Telehealth Platform
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga
Hims & Hers Health, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 8, 2022
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Partners With Carbon Health
Hims & Hers Health Inc (NYSE: HIMS) has partnered with healthcare provider Carbon Health to enable access to a broader range of care options through its... 
Via Benzinga
3 Stocks Under $5 Insiders Are Aggressively Buying
U.S. stocks closed sharply lower, with the Nasdaq Composite dipping around 450 on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
7 Penny Stocks That Actually Have Analyst Buy Ratings
Many penny stocks (stocks trading for less than $5 per share) have little analyst coverage, but these seven have sell-side "buy" ratings. 
Via InvestorPlace
Hims & Hers Announces 2022 Pride Tour Partnership with Drag Superstars Violet Chachki, Gottmik, and LGBTQ Youth Support Organization, The Trevor Project
From Hims & Hers
Via Business Wire
Hers Doubles Down On Commitment To Women’s Wellness With Launch of 6 New Hers Wellness Essentials Supplements
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health, Inc. Reports First Quarter 2022 Financial Results and Raises Full Year 2022 Revenue Outlook
From Hims & Hers Health, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million. 
Via Benzinga
Earnings Preview For Hims & Hers Health
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers... 
Via Benzinga
This Company Is Reportedly Solving Bedroom Performance Issues Behind Closed Doors
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
Upgrades 
Via Benzinga
Hims & Hers Health, Inc. to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers and Carbon Health Partner to Expand Care Options for California Customers
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health Expands Skincare Offerings
Hims & Hers Health Inc (NYSE: HIMS) has expanded its skincare collections, including a facial cleanser, moisturizer, daily SPF, spot corrector, and face oil.... 
Via Benzinga
Hims & Hers Doubles Skincare Product Offerings With a Suite of New Products for Increased Personalized Care to Help Address Common Skincare Concerns
From Hims & Hers Health, Inc.
Via Business Wire
What Cramer Thinks About Hims & Hers Health, Gilead Sciences And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Healthcare Realty Trust Incorporated (NYSE: HR) as the company’s merger with Healthcare Trust of America, Inc. 
Via Benzinga
7 Cheap Stocks to Buy If You Only Have $100 to Spend
You can find many good stocks to buy for under $10. And here are seven cheap stocks that are good buys even if you only have $100 to spend. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022
Upgrades For Alpha Metallurgical Resources Inc (NYSE:AMR), B. Riley Securities upgraded the previous rating of Neutral to Buy. For the fourth quarter, Alpha Metallurgical... 
Via Benzinga
63 Biggest Movers From Yesterday
Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a... 
Via Benzinga
Hims & Hers Health, Inc. to Participate at Citi’s 2022 Virtual Healthcare Conference
From Hims & Hers Health, Inc.
Via Business Wire
Russian Stocks: What’s Going on With SBRCY, YNDX, OGZPY, NOVKY and LUKOY Today?
Russian stocks are on the move today with several shares taking a massive beating on Wednesday and we're diving into that news. 
Via InvestorPlace
SKIN Stock: What’s Going on With The Beauty Health Company Today?
The Beauty Health Company (SKIN) stock is rising higher on Wednesday following the release of its Q4 2021 earnings report. 
Via InvestorPlace
HIMS Stock: 12 Reasons Why Hims & Hers Shares Are Soaring Today
Hims & Hers Health (HIMS) stock is soaring higher on Wednesday thanks to the company's earnings report for the fourth quarter of 2021. 
Via InvestorPlace
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the... 
Via Benzinga
Hims & Hers Health Stock Gains On Solid Q1, FY22 Outlook
Hims & Hers Health Inc (NYSE: HIMS) reported fourth-quarter FY21 sales growth of 104% year-on-year, to $84.7 million, beating the consensus of $76.79 million.... 
Via Benzinga
Hims & Hers Health: Q4 Earnings Insights
Hims & Hers Health (NYSE:HIMS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.